LivaNova PLC (LIVN) is a Medical - Devices company in the Healthcare sector, currently trading at $64.99. It has a SharesGrow Score of 56/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of LIVN = $136.08 (+109.4% from the current price, the stock appears undervalued). Analyst consensus target is LIVN = $76 (+16.8% upside).
Valuation: LIVN trades at a trailing Price-to-Earnings (P/E) of -14.3 (S&P 500 average ~25).
Financials: revenue is $1.4B, +10.8%/yr average growth. Net income is $243M (loss), growing at -34.3%/yr. Net profit margin is -17.5% (negative). Gross margin is 67.7% (-1.5 pp trend).
Balance sheet: total debt is $473M against $1.2B equity (Debt-to-Equity (D/E) ratio 0.39, conservative). Current ratio is 1.36 (adequate). Debt-to-assets is 18.2%. Total assets: $2.6B.
Analyst outlook: 10 / 14 analysts rate LIVN as buy (71%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 71/100 (Pass), Growth 48/100 (Partial), Past 50/100 (Partial), Health 67/100 (Partial), Moat 70/100 (Pass), Future 79/100 (Pass), Income 10/100 (Fail).
